Literature DB >> 7459240

Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis.

R E Leake, L Laing, C McArdle, D C Smith.   

Abstract

The relationship between oestrogen receptor (RE) content of primary breast cancer and subsequent prognosis was examined with regard to nodal status. It was found that, within a particular nodal group, patients with tumours containing fully functional RE experienced a longer disease-free interval than those with RE- disease. An earlier observation that RE- primary disease gave rise to distant metastases as first site of recurrence more frequently than did RE+ disease, was not sustained. However, patients with RE+ primary disease had a much reduced chance of dying from cancer within a 3-year period.

Entities:  

Keywords:  Biology; Breast Cancer; Cancer; Developed Countries; Diseases; Europe; Hormone Receptors; Membrane Proteins; Mortality; Neoplasms; Northern Europe; Physiology; Research Methodology; Retrospective Studies; Scotland; Studies; United Kingdom

Mesh:

Substances:

Year:  1981        PMID: 7459240      PMCID: PMC2010498          DOI: 10.1038/bjc.1981.9

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  7 in total

Review 1.  Adjuvant chemotherapy of breast cancer.

Authors:  G Bonadonna
Journal:  Br J Hosp Med       Date:  1980-01

2.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.

Authors:  W A Knight; R B Livingston; E J Gregory; W L McGuire
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

3.  Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.

Authors:  J S Meyer; B R Rao; S C Stevens; W L White
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

4.  Oestrogen receptors and prognosis in early breast cancer.

Authors:  T Cooke; D George; R Shields; P Maynard; K Griffiths
Journal:  Lancet       Date:  1979-05-12       Impact factor: 79.321

5.  Relationship of oestrogen-receptor status to survival in breast cancer.

Authors:  H M Bishop; R W Blamey; C W Elston; J L Haybittle; R I Nicholson; K Griffiths
Journal:  Lancet       Date:  1979-08-11       Impact factor: 79.321

6.  Correlation of estrophilin content of primary mammary cancer to eventual endocrine treatment.

Authors:  G E Block; R S Ellis; E DeSombre; E Jensen
Journal:  Ann Surg       Date:  1978-09       Impact factor: 12.969

7.  Prognostic value of estrogen receptors in primary breast cancer.

Authors:  R Hähnel; T Woodings; A B Vivian
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

  7 in total
  12 in total

1.  Adjuvant chemotherapy of breast cancer: hope--reality--hazard?

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1984-02-15

2.  The effect of molybdate on the intracellular distribution of estrogen receptor in mammary tumors.

Authors:  C B Lazier; J Richman; K Lonergan
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

3.  Soluble and nuclear type I and II androgen-binding sites in benign hyperplasia and cancer of the human prostate.

Authors:  L Castagnetta; G Carruba; E Fecarotta; M Lo Casto; R Cusimano; M Pavone-Macaluso
Journal:  Urol Res       Date:  1992

4.  Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status.

Authors:  R J Pegoraro; D Nirmul; S G Reinach; J P Jordaan; S M Joubert
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 5.  Chemotherapy of breast cancer.

Authors:  L S Perlow; J F Holland
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

6.  A case of breast carcinoma in association with in vitro fertilization.

Authors:  R W Laing; M G Glaser; G S Barrett
Journal:  J R Soc Med       Date:  1989-08       Impact factor: 18.000

7.  Do multiple oestrogen receptor assays give significant additional information for the management of breast cancer?

Authors:  L Castagnetta; A Traina; A Di Carlo; G Carruba; M Lo Casto; M Mesiti; R Leake
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

8.  Nuclear and cytoplasmic oestrogen receptors in squamous carcinoma of the cervix.

Authors:  W P Soutter; R J Pegoraro; R W Green-Thompson; D V Naidoo; S M Joubert; R H Philpott
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

9.  A seven-nuclear receptor-based prognostic signature in breast cancer.

Authors:  F Wu; W Chen; X Kang; L Jin; J Bai; H Zhang; X Zhang
Journal:  Clin Transl Oncol       Date:  2020-11-18       Impact factor: 3.405

10.  Intra-tumoural variation of oestrogen receptor status in endometrial cancer.

Authors:  L Castagnetta; M Lo Casto; T Mercadante; L Polito; S Cowan; R E Leake
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.